Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Attention Deficit Disorder with Hyperactivity

3,3',5-triiodothyroacetic acid has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anzai, R1
Adachi, M1
Sho, N1
Muroya, K1
Asakura, Y1
Onigata, K1

Reviews

1 review available for 3,3',5-triiodothyroacetic acid and Attention Deficit Disorder with Hyperactivity

ArticleYear
Long-term 3,5,3'-triiodothyroacetic acid therapy in a child with hyperthyroidism caused by thyroid hormone resistance: pharmacological study and therapeutic recommendations.
    Thyroid : official journal of the American Thyroid Association, 2012, Volume: 22, Issue:10

    Topics: Adolescent; Adult; Atrial Premature Complexes; Attention Deficit Disorder with Hyperactivity; Child;

2012